1. Poon MA, O’Connel MJ, Moertel CG, et al. Biochemical modulation of fluorouracil with leucovorin. Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989, 7, 1407–1417.
2. 5-fluorouracil concentrations in human plasma following R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration;Au;Cancer Res,1979
3. Van Groeningen CJ, Pinedo HM, Heddes J, et al. Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule. Cancer Res 1988, 48, 6956–6961.
4. Remick SC, Grem JL, Fischer PH, et al. Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion. Cancer Res 1990, 50, 2667–2672.
5. Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole;Trump;J Clin Oncol,1991